100509,0,Admission,O
100509,0,Date,O
100509,0,:,O
100509,0,[,O
100509,0,*,O
100509,0,*,O
100509,0,2172-8-25,O
100509,0,*,O
100509,0,*,O
100509,0,],O
100509,0,Discharge,O
100509,0,Date,O
100509,0,:,O
100509,0,[,O
100509,0,*,O
100509,0,*,O
100509,0,2172-9-6,O
100509,0,*,O
100509,0,*,O
100509,0,],O
100509,0,Date,O
100509,0,of,O
100509,0,Birth,O
100509,0,:,O
100509,0,[,O
100509,0,*,O
100509,0,*,O
100509,0,2114-3-8,O
100509,0,*,O
100509,0,*,O
100509,0,],O
100509,0,Sex,O
100509,0,:,O
100509,0,F,O
100509,0,Service,O
100509,0,:,O
100509,0,MEDICINE,O
100509,0,Allergies,O
100509,0,:,O
100509,0,Patient,O
100509,0,recorded,O
100509,0,as,O
100509,0,having,O
100509,0,No,O
100509,0,Known,O
100509,0,Allergies,O
100509,0,to,O
100509,0,Drugs,O
100509,0,Attending,O
100509,0,:,O
100509,0,[,O
100509,0,*,O
100509,0,*,O
100509,0,First,O
100509,0,Name3,O
100509,0,(,O
100509,0,LF,O
100509,0,),O
100509,0,3984,O
100509,0,*,O
100509,0,*,O
100509,0,],O
100509,0,Chief,O
100509,0,Complaint,O
100509,0,:,O
100509,0,dyspnea,O
100509,0,",",O
100509,0,hoarseness,O
100509,0,",",O
100509,0,and,O
100509,0,cough,O
100509,0,Major,O
100509,0,Surgical,O
100509,0,or,O
100509,0,Invasive,O
100509,0,Procedure,O
100509,0,:,O
100509,0,Bronchoscopy,O
100509,0,x2,O
100509,0,Tracheal,O
100509,0,Y-stent,O
100509,0,placement,O
100509,0,[,O
100509,0,*,O
100509,0,*,O
100509,0,2172-8-25,O
100509,0,*,O
100509,0,*,O
100509,0,],O
100509,0,Pigtail,O
100509,0,catheter,O
100509,0,placement,O
100509,0,(,O
100509,0,right,O
100509,0,),O
100509,0,[,O
100509,0,*,O
100509,0,*,O
100509,0,2172-8-25,O
100509,0,*,O
100509,1,*,O
100509,1,],O
100509,1,for,O
100509,1,pleural,O
100509,1,effusion,O
100509,1,Intubation,O
100509,1,[,O
100509,1,*,O
100509,1,*,O
100509,1,2172-8-25,O
100509,1,*,O
100509,1,*,O
100509,1,],O
100509,1,",",O
100509,1,re-intubated,O
100509,1,[,O
100509,1,*,O
100509,1,*,O
100509,1,2172-8-26,O
100509,1,*,O
100509,1,*,O
100509,1,],O
100509,1,after,O
100509,1,attempted,O
100509,1,extubation,O
100509,1,Chest,O
100509,1,tube,O
100509,1,placement,O
100509,1,(,O
100509,1,right,O
100509,1,),O
100509,1,[,O
100509,1,*,O
100509,1,*,O
100509,1,2172-8-26,O
100509,1,*,O
100509,1,*,O
100509,1,],O
100509,1,for,O
100509,1,pneumothorax,O
100509,1,Radiation,O
100509,1,therapy,O
100509,1,x2,O
100509,1,Chemotherapy,B-Drug
100509,1,x3days,O
100509,1,Lumbar,O
100509,1,puncture,O
100509,1,[,O
100509,1,*,O
100509,1,*,O
100509,1,2172-9-3,O
100509,1,*,O
100509,1,*,O
100509,1,],O
100509,1,History,O
100509,1,of,O
100509,1,Present,O
100509,1,Illness,O
100509,1,:,O
100509,1,58,O
100509,1,year-old,O
100509,1,female,O
100509,1,",",O
100509,1,60,O
100509,1,pack-year,O
100509,1,smoker,O
100509,1,",",O
100509,1,with,O
100509,1,dyspnea,O
100509,1,",",O
100509,1,hoarseness,O
100509,1,",",O
100509,1,and,O
100509,1,cough,O
100509,1,x1,O
100509,1,month,O
100509,1,admitted,O
100509,1,to,O
100509,1,[,O
100509,1,*,O
100509,1,*,O
100509,1,Hospital1,O
100509,1,18,O
100509,1,*,O
100509,1,*,O
100509,1,],O
100509,1,SICU,O
100509,1,[,O
100509,1,*,O
100509,1,*,O
100509,1,2172-8-25,O
100509,1,*,O
100509,1,*,O
100509,1,],O
100509,1,after,O
100509,1,found,O
100509,1,to,O
100509,1,have,O
100509,1,large,O
100509,1,mediastinal,O
100509,2,mass,O
100509,2,",",O
100509,2,today,O
100509,2,found,O
100509,2,to,O
100509,2,be,O
100509,2,poorly-differentiated,O
100509,2,carcinoma,O
100509,2,",",O
100509,2,suspected,O
100509,2,small,O
100509,2,cell,O
100509,2,.,O
100509,2,On,O
100509,2,initial,O
100509,2,evaluation,O
100509,2,",",O
100509,2,patient,O
100509,2,was,O
100509,2,found,O
100509,2,to,O
100509,2,have,O
100509,2,3mm,O
100509,2,opening,O
100509,2,of,O
100509,2,distal,O
100509,2,trachea,O
100509,2,secondary,O
100509,2,to,O
100509,2,external,O
100509,2,compression,O
100509,2,from,O
100509,2,mediastinal,O
100509,2,mass,O
100509,2,",",O
100509,2,RUL,O
100509,2,mass,O
100509,2,",",O
100509,2,RUL,O
100509,2,collapse,O
100509,2,",",O
100509,2,and,O
100509,2,clinical,O
100509,2,findings,O
100509,2,consistent,O
100509,2,with,O
100509,2,SVC,O
100509,2,sydrome,O
100509,2,.,O
100509,2,Y-stent,O
100509,2,was,O
100509,2,placed,O
100509,2,that,O
100509,2,evening,O
100509,2,",",O
100509,2,in,O
100509,2,addition,O
100509,2,to,O
100509,2,Pigtail,O
100509,2,catheter,O
100509,2,for,O
100509,2,right-sided,O
100509,2,effusion,O
100509,2,.,O
100509,2,Patient,O
100509,2,remained,O
100509,2,intubated,O
100509,2,following,O
100509,2,surgery,O
100509,2,",",O
100509,2,on,O
100509,2,paralytics,O
100509,2,due,O
100509,2,to,O
100509,2,low-lying,O
100509,2,ET,O
100509,2,tube,O
100509,2,and,O
100509,2,small,O
100509,2,volume,O
100509,2,bleeding,O
100509,2,after,O
100509,2,endobronchial,O
100509,2,biopsy,O
100509,2,.,O
100509,3,On,O
100509,3,[,O
100509,3,*,O
100509,3,*,O
100509,3,2172-8-26,O
100509,3,*,O
100509,3,*,O
100509,3,],O
100509,3,",",O
100509,3,extubated,O
100509,3,was,O
100509,3,attempted,O
100509,3,.,O
100509,3,Patient,O
100509,3,was,O
100509,3,reintubated,O
100509,3,within,O
100509,3,10,O
100509,3,minutes,O
100509,3,due,O
100509,3,to,O
100509,3,neurological,O
100509,3,unresponsiveness,O
100509,3,",",O
100509,3,hypoxia,O
100509,3,(,O
100509,3,O2,O
100509,3,saturation,O
100509,3,80s,O
100509,3,),O
100509,3,",",O
100509,3,and,O
100509,3,hemodynamic,O
100509,3,instability,O
100509,3,.,O
100509,3,She,O
100509,3,was,O
100509,3,found,O
100509,3,to,O
100509,3,have,O
100509,3,a,O
100509,3,right,O
100509,3,pneumothorax,O
100509,3,",",O
100509,3,which,O
100509,3,improved,O
100509,3,with,O
100509,3,subsequent,O
100509,3,placement,O
100509,3,of,O
100509,3,chest,O
100509,3,tube,O
100509,3,.,O
100509,3,Patient,O
100509,3,was,O
100509,3,also,O
100509,3,noted,O
100509,3,to,O
100509,3,have,O
100509,3,pericardial,O
100509,3,effusion,O
100509,3,;,O
100509,3,given,O
100509,3,absence,O
100509,3,of,O
100509,3,physiologic,O
100509,3,tamponade,O
100509,3,",",O
100509,3,cardiology,O
100509,3,decided,O
100509,3,against,O
100509,3,pericardiocentesis,O
100509,3,.,O
100509,3,.,O
100509,3,Hospital,O
100509,3,course,O
100509,3,also,O
100509,3,complicated,O
100509,3,by,O
100509,3,hyponatremia,O
100509,3,on,O
100509,3,admission,O
100509,3,(,O
100509,3,Na,O
100509,3,118,O
100509,3,),O
100509,3,attributed,O
100509,3,to,O
100509,3,SIADH,O
100509,3,and,O
100509,3,improved,O
100509,3,with,O
100509,3,fluid,O
100509,3,restriction,O
100509,3,(,O
100509,3,Na,O
100509,3,126,O
100509,3,),O
100509,3,.,O
100509,4,Also,O
100509,4,with,O
100509,4,hypotension,O
100509,4,(,O
100509,4,sBP,O
100509,4,90s,O
100509,4,),O
100509,4,following,O
100509,4,reintubation,O
100509,4,on,O
100509,4,[,O
100509,4,*,O
100509,4,*,O
100509,4,2172-8-26,O
100509,4,*,O
100509,4,*,O
100509,4,],O
100509,4,.,O
100509,4,Given,O
100509,4,hyperkalemia,O
100509,4,",",O
100509,4,hyponatremia,O
100509,4,adrenal,O
100509,4,insufficiency,O
100509,4,was,O
100509,4,suspected,O
100509,4,;,O
100509,4,evaluated,O
100509,4,by,O
100509,4,endocrine,O
100509,4,team,O
100509,4,who,O
100509,4,recommended,O
100509,4,stress,O
100509,4,dose,O
100509,4,steroids,B-Drug
100509,4,pending,O
100509,4,further,O
100509,4,evaluation,O
100509,4,of,O
100509,4,etiology,O
100509,4,of,O
100509,4,hypotension,O
100509,4,.,O
100509,4,Also,O
100509,4,with,O
100509,4,non-anion,O
100509,4,gap,O
100509,4,metabolic,O
100509,4,acidosis,O
100509,4,",",O
100509,4,transient,O
100509,4,hypothermia,O
100509,4,(,O
100509,4,T,O
100509,4,95,O
100509,4,[,O
100509,4,*,O
100509,4,*,O
100509,4,2172-8-26,O
100509,4,*,O
100509,4,*,O
100509,4,],O
100509,4,),O
100509,4,of,O
100509,4,unknown,O
100509,4,etiology,O
100509,4,.,O
100509,4,.,O
100509,4,Per,O
100509,4,report,O
100509,4,",",O
100509,4,patient,O
100509,4,has,O
100509,4,done,O
100509,4,well,O
100509,4,today,O
100509,4,.,O
100509,5,She,O
100509,5,remains,O
100509,5,intubated,O
100509,5,",",O
100509,5,on,O
100509,5,pressure,O
100509,5,support,O
100509,5,.,O
100509,5,Given,O
100509,5,the,O
100509,5,above,O
100509,5,pathology,O
100509,5,results,O
100509,5,",",O
100509,5,patient,O
100509,5,is,O
100509,5,transferred,O
100509,5,to,O
100509,5,the,O
100509,5,medical,O
100509,5,ICU,O
100509,5,(,O
100509,5,[,O
100509,5,*,O
100509,5,*,O
100509,5,Hospital,O
100509,5,Ward,O
100509,5,Name,O
100509,5,332,O
100509,5,*,O
100509,5,*,O
100509,5,],O
100509,5,),O
100509,5,for,O
100509,5,radiation,O
100509,5,therapy,O
100509,5,.,O
100509,5,.,O
100509,5,On,O
100509,5,arrival,O
100509,5,to,O
100509,5,the,O
100509,5,[,O
100509,5,*,O
100509,5,*,O
100509,5,Hospital,O
100509,5,332,O
100509,5,*,O
100509,5,*,O
100509,5,],O
100509,5,medical,O
100509,5,ICU,O
100509,5,",",O
100509,5,patient,O
100509,5,is,O
100509,5,intubated,O
100509,5,",",O
100509,5,sedated,O
100509,5,",",O
100509,5,and,O
100509,5,unable,O
100509,5,to,O
100509,5,provide,O
100509,5,history,O
100509,5,.,O
100509,5,Past,O
100509,5,Medical,O
100509,5,History,O
100509,5,:,O
100509,5,Hypertension,O
100509,5,s/p,O
100509,5,cerebral,O
100509,5,sneurysm,O
100509,5,repair,O
100509,5,x3,O
100509,5,GERD,O
100509,5,Social,O
100509,5,History,O
100509,5,:,O
100509,5,Per,O
100509,5,review,O
100509,5,of,O
100509,5,records,O
100509,5,",",O
100509,5,60,O
100509,5,pack-year,O
100509,5,history,O
100509,5,Family,O
100509,5,History,O
100509,5,:,O
100509,5,Unable,O
100509,5,to,O
100509,5,obtain,O
100509,5,.,O
100509,6,Physical,O
100509,6,Exam,O
100509,6,:,O
100509,6,On,O
100509,6,[,O
100509,6,*,O
100509,6,*,O
100509,6,Hospital,O
100509,6,Unit,O
100509,6,Name,O
100509,6,153,O
100509,6,*,O
100509,6,*,O
100509,6,],O
100509,6,admission,O
100509,6,[,O
100509,6,*,O
100509,6,*,O
100509,6,2172-8-27,O
100509,6,*,O
100509,6,*,O
100509,6,],O
100509,6,:,O
100509,6,96.0,O
100509,6,",",O
100509,6,103,O
100509,6,",",O
100509,6,120/68,O
100509,6,",",O
100509,6,13,O
100509,6,",",O
100509,6,97,O
100509,6,%,O
100509,6,[,O
100509,6,PS,O
100509,6,14/5,O
100509,6,50,O
100509,6,%,O
100509,6,],O
100509,6,General,O
100509,6,:,O
100509,6,Intubated,O
100509,6,",",O
100509,6,sedated,O
100509,6,",",O
100509,6,not,O
100509,6,responsive,O
100509,6,to,O
100509,6,verbal,O
100509,6,stimuli,O
100509,6,;,O
100509,6,swelling,O
100509,6,of,O
100509,6,head,O
100509,6,",",O
100509,6,neck,O
100509,6,",",O
100509,6,and,O
100509,6,upper,O
100509,6,extremities,O
100509,6,;,O
100509,6,wasting,O
100509,6,of,O
100509,6,lower,O
100509,6,extremities,O
100509,6,Skin,O
100509,6,:,O
100509,6,Mottled,O
100509,6,at,O
100509,6,arms,O
100509,6,and,O
100509,6,superior,O
100509,6,to,O
100509,6,nipple,O
100509,6,line,O
100509,6,;,O
100509,6,telangiectasias,O
100509,6,on,O
100509,6,chest,O
100509,6,wall,O
100509,6,HEENT,O
100509,6,:,O
100509,6,Temporal,O
100509,6,wasting,O
100509,6,;,O
100509,6,pupils,O
100509,6,symmetric,O
100509,6,",",O
100509,6,minimal,O
100509,6,reactivity,O
100509,6,to,O
100509,6,light,O
100509,6,;,O
100509,6,sclerae,O
100509,6,anicetric,O
100509,6,;,O
100509,6,scleral,O
100509,6,edema,O
100509,6,;,O
100509,6,dry,O
100509,7,mucous,O
100509,7,membranes,O
100509,7,Neck,O
100509,7,:,O
100509,7,Large,O
100509,7,;,O
100509,7,unable,O
100509,7,to,O
100509,7,appreciate,O
100509,7,neck,O
100509,7,veins,O
100509,7,secondary,O
100509,7,to,O
100509,7,swelling,O
100509,7,;,O
100509,7,right,O
100509,7,anterior,O
100509,7,chain,O
100509,7,palpable,O
100509,7,lymph,O
100509,7,node,O
100509,7,Chest,O
100509,7,:,O
100509,7,Right,O
100509,7,chest,O
100509,7,tube,O
100509,7,",",O
100509,7,pigtail,O
100509,7,catheter,O
100509,7,in,O
100509,7,place,O
100509,7,Lungs,O
100509,7,:,O
100509,7,Upper,O
100509,7,airway,O
100509,7,noise,O
100509,7,;,O
100509,7,by,O
100509,7,anterior,O
100509,7,ausculation,O
100509,7,",",O
100509,7,few,O
100509,7,expiratory,O
100509,7,wheezes,O
100509,7,diffusely,O
100509,7,;,O
100509,7,breath,O
100509,7,sounds,O
100509,7,appreciable,O
100509,7,in,O
100509,7,all,O
100509,7,lung,O
100509,7,fields,O
100509,7,CV,O
100509,7,:,O
100509,7,Tachycardic,O
100509,7,;,O
100509,7,regular,O
100509,7,rhythm,O
100509,7,;,O
100509,7,pronounced,O
100509,7,S2,O
100509,7,at,O
100509,7,apex,O
100509,7,;,O
100509,7,I/VI,O
100509,7,early,O
100509,7,systolic,O
100509,7,murmur,O
100509,7,at,O
100509,7,left,O
100509,7,LLSB,O
100509,7,;,O
100509,7,unable,O
100509,7,to,O
100509,7,assess,O
100509,7,pulsus,O
100509,7,paradoxus,O
100509,7,given,O
100509,7,quiet,O
100509,7,Korsakoff,O
100509,7,sounds,O
100509,7,Abdomen,O
100509,7,:,O
100509,7,Hypoactive,O
100509,7,bowel,O
100509,7,sounds,O
100509,7,;,O
100509,7,soft,O
100509,7,",",O
100509,7,non-distended,O
100509,7,GU,O
100509,7,:,O
100509,7,Foley,O
100509,7,Ext,O
100509,7,:,O
100509,7,Right,O
100509,7,DP,O
100509,7,1+,O
100509,7,",",O
100509,8,left,O
100509,8,DP,O
100509,8,appreciated,O
100509,8,with,O
100509,8,Doppler,O
100509,8,;,O
100509,8,no,O
100509,8,lower,O
100509,8,extremity,O
100509,8,edema,O
100509,8,;,O
100509,8,upper,O
100509,8,extremity,O
100509,8,nonpitting,O
100509,8,edema,O
100509,8,Pertinent,O
100509,8,Results,O
100509,8,:,O
100509,8,On,O
100509,8,admission,O
100509,8,[,O
100509,8,*,O
100509,8,*,O
100509,8,2172-8-26,O
100509,8,*,O
100509,8,*,O
100509,8,],O
100509,8,:,O
100509,8,WBC-11.1,O
100509,8,*,O
100509,8,RBC-3.47,O
100509,8,*,O
100509,8,Hgb-10.9,O
100509,8,*,O
100509,8,Hct-31.9,O
100509,8,*,O
100509,8,MCV-92,O
100509,8,MCH-31.5,O
100509,8,MCHC-34.2,O
100509,8,RDW-12.5,O
100509,8,Plt,O
100509,8,Ct-393,O
100509,8,Glucose-112,O
100509,8,*,O
100509,8,UreaN-9,O
100509,8,Creat-0.8,O
100509,8,Na-118,O
100509,8,*,O
100509,8,K-4.8,O
100509,8,Cl-82,O
100509,8,*,O
100509,8,HCO3-24,O
100509,8,AnGap-17,O
100509,8,ALT-7,O
100509,8,AST-21,O
100509,8,LD,O
100509,8,(,O
100509,8,LDH,O
100509,8,),O
100509,8,-584,O
100509,8,*,O
100509,8,AlkPhos-75,O
100509,8,TotBili-0.2,O
100509,8,Cortsol-25.7,O
100509,8,*,O
100509,8,Hgb-13.5,O
100509,8,calcHCT-41,O
100509,8,O2,O
100509,8,Sat-82,O
100509,8,.,O
100509,8,Imaging,O
100509,8,:,O
100509,8,[,O
100509,8,*,O
100509,8,*,O
100509,8,8-25,O
100509,8,*,O
100509,8,*,O
100509,8,],O
100509,8,CT,O
100509,8,Chest,O
100509,8,without,O
100509,8,contrast,O
100509,8,:,O
100509,8,1,O
100509,8,.,O
100509,9,Large,O
100509,9,mediastinal,O
100509,9,mass,O
100509,9,causes,O
100509,9,narrowing,O
100509,9,of,O
100509,9,the,O
100509,9,right,O
100509,9,pulmonary,O
100509,9,artery,O
100509,9,",",O
100509,9,superior,O
100509,9,vena,O
100509,9,cava,O
100509,9,",",O
100509,9,and,O
100509,9,trachea,O
100509,9,and,O
100509,9,occlusion,O
100509,9,of,O
100509,9,the,O
100509,9,pulmonary,O
100509,9,artery,O
100509,9,supplying,O
100509,9,the,O
100509,9,right,O
100509,9,upper,O
100509,9,lobe,O
100509,9,in,O
100509,9,addition,O
100509,9,to,O
100509,9,the,O
100509,9,right,O
100509,9,upper,O
100509,9,lobe,O
100509,9,bronchus,O
100509,9,.,O
100509,9,These,O
100509,9,findings,O
100509,9,are,O
100509,9,most,O
100509,9,concerning,O
100509,9,for,O
100509,9,a,O
100509,9,primary,O
100509,9,lung,O
100509,9,carcinoma,O
100509,9,.,O
100509,9,2,O
100509,9,.,O
100509,9,Right,O
100509,9,upper,O
100509,9,lobe,O
100509,9,collapse,O
100509,9,with,O
100509,9,nonenhancing,O
100509,9,lung,O
100509,9,parenchyma,O
100509,9,.,O
100509,9,Tumor,O
100509,9,involvement,O
100509,9,can,O
100509,9,not,O
100509,9,be,O
100509,9,excluded,O
100509,9,.,O
100509,9,Atelectasis,O
100509,9,of,O
100509,9,the,O
100509,9,right,O
100509,9,lower,O
100509,9,and,O
100509,9,middle,O
100509,9,lobe,O
100509,9,.,O
100509,9,3,O
100509,9,.,O
100509,10,Large,O
100509,10,right,O
100509,10,pleural,O
100509,10,effusion,O
100509,10,.,O
100509,10,.,O
100509,10,[,O
100509,10,*,O
100509,10,*,O
100509,10,8-25,O
100509,10,*,O
100509,10,*,O
100509,10,],O
100509,10,Tracheal,O
100509,10,mass,O
100509,10,tissue,O
100509,10,pathology,O
100509,10,:,O
100509,10,Immunohistochemical,O
100509,10,studies,O
100509,10,show,O
100509,10,that,O
100509,10,tumor,O
100509,10,cells,O
100509,10,are,O
100509,10,positively,O
100509,10,stained,O
100509,10,by,O
100509,10,TTF-1,O
100509,10,and,O
100509,10,CK7,O
100509,10,;,O
100509,10,they,O
100509,10,are,O
100509,10,negative,O
100509,10,for,O
100509,10,CK20,O
100509,10,",",O
100509,10,chromogranin,O
100509,10,",",O
100509,10,and,O
100509,10,synaptophysin,O
100509,10,.,O
100509,10,The,O
100509,10,tumor,O
100509,10,shows,O
100509,10,areas,O
100509,10,of,O
100509,10,necrosis,O
100509,10,",",O
100509,10,extensive,O
100509,10,apoptosis,O
100509,10,and,O
100509,10,focal,O
100509,10,lymphatic,O
100509,10,vascular,O
100509,10,invasion,O
100509,10,;,O
100509,10,some,O
100509,10,areas,O
100509,10,the,O
100509,10,tumor,O
100509,10,cell,O
100509,10,size,O
100509,10,approaching,O
100509,10,that,O
100509,10,of,O
100509,10,a,O
100509,10,small,O
100509,10,cell,O
100509,10,carcinoma,O
100509,10,",",O
100509,10,but,O
100509,10,much,O
100509,10,of,O
100509,10,the,O
100509,10,tumor,O
100509,10,has,O
100509,10,larger,O
100509,10,nuclei,O
100509,10,.,O
100509,11,Overall,O
100509,11,",",O
100509,11,the,O
100509,11,tumor,O
100509,11,probably,O
100509,11,fits,O
100509,11,into,O
100509,11,the,O
100509,11,spectrum,O
100509,11,of,O
100509,11,a,O
100509,11,small,O
100509,11,cell,O
100509,11,carcinoma,O
100509,11,of,O
100509,11,lung,O
100509,11,.,O
100509,11,.,O
100509,11,[,O
100509,11,*,O
100509,11,*,O
100509,11,8-26,O
100509,11,*,O
100509,11,*,O
100509,11,],O
100509,11,Pleural,O
100509,11,fluid,O
100509,11,cytology,O
100509,11,:,O
100509,11,Rare,O
100509,11,groups,O
100509,11,of,O
100509,11,epithelioid,O
100509,11,cells,O
100509,11,",",O
100509,11,too,O
100509,11,few,O
100509,11,to,O
100509,11,characterize,O
100509,11,further,O
100509,11,.,O
100509,11,By,O
100509,11,immunohistochemistry,O
100509,11,:,O
100509,11,mesothelial,O
100509,11,cells,O
100509,11,stain,O
100509,11,for,O
100509,11,calretinin,O
100509,11,and,O
100509,11,WT-1,O
100509,11,.,O
100509,11,Epithelial,O
100509,11,markers,O
100509,11,[,O
100509,11,*,O
100509,11,*,O
100509,11,Last,O
100509,11,Name,O
100509,11,(,O
100509,11,un,O
100509,11,),O
100509,11,*,O
100509,11,*,O
100509,11,],O
100509,11,-31,O
100509,11,",",O
100509,11,CEA,O
100509,11,",",O
100509,11,and,O
100509,11,B72.3,O
100509,11,are,O
100509,11,negative,O
100509,11,.,O
100509,11,Rare,O
100509,11,cells,O
100509,11,are,O
100509,11,highlighted,O
100509,11,by,O
100509,11,TTF-1,O
100509,11,;,O
100509,11,however,O
100509,11,",",O
100509,11,these,O
100509,11,cells,O
100509,11,are,O
100509,11,not,O
100509,11,cytologically,O
100509,11,atypical,O
100509,11,and,O
100509,11,may,O
100509,11,represent,O
100509,11,non-specific,O
100509,11,reactivity,O
100509,11,.,O
100509,12,.,O
100509,12,[,O
100509,12,*,O
100509,12,*,O
100509,12,8-26,O
100509,12,*,O
100509,12,*,O
100509,12,],O
100509,12,EKG,O
100509,12,:,O
100509,12,Sinus,O
100509,12,tachycardia,O
100509,12,.,O
100509,12,Low,O
100509,12,QRS,O
100509,12,voltage,O
100509,12,in,O
100509,12,limb,O
100509,12,leads,O
100509,12,.,O
100509,12,No,O
100509,12,previous,O
100509,12,tracing,O
100509,12,available,O
100509,12,for,O
100509,12,comparison,O
100509,12,.,O
100509,12,.,O
100509,12,[,O
100509,12,*,O
100509,12,*,O
100509,12,8-26,O
100509,12,*,O
100509,12,*,O
100509,12,],O
100509,12,Echo,O
100509,12,:,O
100509,12,The,O
100509,12,left,O
100509,12,atrium,O
100509,12,and,O
100509,12,right,O
100509,12,atrium,O
100509,12,are,O
100509,12,normal,O
100509,12,in,O
100509,12,cavity,O
100509,12,size,O
100509,12,.,O
100509,12,There,O
100509,12,is,O
100509,12,mild,O
100509,12,symmetric,O
100509,12,left,O
100509,12,ventricular,O
100509,12,hypertrophy,O
100509,12,with,O
100509,12,normal,O
100509,12,cavity,O
100509,12,size,O
100509,12,and,O
100509,12,regional/global,O
100509,12,systolic,O
100509,12,function,O
100509,12,(,O
100509,12,LVEF,O
100509,12,>,O
100509,12,55,O
100509,12,%,O
100509,12,),O
100509,12,.,O
100509,12,Right,O
100509,12,ventricular,O
100509,12,chamber,O
100509,12,size,O
100509,12,and,O
100509,12,free,O
100509,12,wall,O
100509,12,motion,O
100509,12,are,O
100509,12,normal,O
100509,12,.,O
100509,13,The,O
100509,13,aortic,O
100509,13,valve,O
100509,13,leaflets,O
100509,13,(,O
100509,13,3,O
100509,13,),O
100509,13,appear,O
100509,13,structurally,O
100509,13,normal,O
100509,13,with,O
100509,13,good,O
100509,13,leaflet,O
100509,13,excursion,O
100509,13,and,O
100509,13,no,O
100509,13,aortic,O
100509,13,regurgitation,O
100509,13,.,O
100509,13,The,O
100509,13,mitral,O
100509,13,valve,O
100509,13,appears,O
100509,13,structurally,O
100509,13,normal,O
100509,13,with,O
100509,13,trivial,O
100509,13,mitral,O
100509,13,regurgitation,O
100509,13,.,O
100509,13,There,O
100509,13,is,O
100509,13,a,O
100509,13,small,O
100509,13,to,O
100509,13,moderate,O
100509,13,sized,O
100509,13,",",O
100509,13,primarily,O
100509,13,anterior,O
100509,13,pericardial,O
100509,13,effusion,O
100509,13,without,O
100509,13,right,O
100509,13,ventricular,O
100509,13,diastolic,O
100509,13,collapse,O
100509,13,.,O
100509,13,IMPRESSION,O
100509,13,:,O
100509,13,Suboptimal,O
100509,13,image,O
100509,13,quality,O
100509,13,.,O
100509,13,Mild-moderate,O
100509,13,",",O
100509,13,primarily,O
100509,13,anterior,O
100509,13,pericardial,O
100509,13,effusion,O
100509,13,.,O
100509,13,Mild,O
100509,13,symmetric,O
100509,13,left,O
100509,13,ventricular,O
100509,13,hypertrophy,O
100509,13,with,O
100509,13,preserved,O
100509,13,global,O
100509,13,and,O
100509,13,regional,O
100509,13,biventricular,O
100509,13,systolic,O
100509,13,function,O
100509,13,.,O
100509,13,If,O
100509,13,clinically,O
100509,13,indicated,O
100509,13,",",O
100509,13,a,O
100509,13,follow-up,O
100509,13,study,O
100509,13,is,O
100509,13,suggested,O
100509,13,.,O
100509,14,.,O
100509,14,[,O
100509,14,*,O
100509,14,*,O
100509,14,8-27,O
100509,14,*,O
100509,14,*,O
100509,14,],O
100509,14,CT,O
100509,14,chest/abdomen/pelvis,O
100509,14,with,O
100509,14,and,O
100509,14,without,O
100509,14,contrast,O
100509,14,:,O
100509,14,1,O
100509,14,.,O
100509,14,Vascular,O
100509,14,findings,O
100509,14,unchanged,O
100509,14,from,O
100509,14,[,O
100509,14,*,O
100509,14,*,O
100509,14,2172-8-25,O
100509,14,*,O
100509,14,*,O
100509,14,],O
100509,14,.,O
100509,14,Narrowing,O
100509,14,of,O
100509,14,SVC,O
100509,14,and,O
100509,14,left,O
100509,14,brachiocephalic,O
100509,14,vein,O
100509,14,by,O
100509,14,large,O
100509,14,mediastinal,O
100509,14,mass,O
100509,14,.,O
100509,14,The,O
100509,14,SVC,O
100509,14,is,O
100509,14,narrowed,O
100509,14,to,O
100509,14,approximately,O
100509,14,5,O
100509,14,mm,O
100509,14,over,O
100509,14,a,O
100509,14,region,O
100509,14,extending,O
100509,14,3,O
100509,14,cm,O
100509,14,in,O
100509,14,craniocaudal,O
100509,14,dimension,O
100509,14,.,O
100509,14,Indirect,O
100509,14,evidence,O
100509,14,of,O
100509,14,right,O
100509,14,brachiocephalic,O
100509,14,vein,O
100509,14,occlusion,O
100509,14,",",O
100509,14,likely,O
100509,14,complete,O
100509,14,.,O
100509,14,Unchanged,O
100509,14,narrowing,O
100509,14,of,O
100509,14,right,O
100509,14,pulmonary,O
100509,14,artery,O
100509,14,.,O
100509,15,Splayed,O
100509,15,but,O
100509,15,patent,O
100509,15,aortic,O
100509,15,arch,O
100509,15,branches,O
100509,15,.,O
100509,15,2,O
100509,15,.,O
100509,15,Interval,O
100509,15,decrease,O
100509,15,in,O
100509,15,large,O
100509,15,right,O
100509,15,pleural,O
100509,15,effusion,O
100509,15,",",O
100509,15,with,O
100509,15,small,O
100509,15,anterior,O
100509,15,pneumothorax,O
100509,15,.,O
100509,15,Right,O
100509,15,chest,O
100509,15,tube,O
100509,15,terminating,O
100509,15,at,O
100509,15,apex,O
100509,15,.,O
100509,15,3,O
100509,15,.,O
100509,15,No,O
100509,15,interval,O
100509,15,change,O
100509,15,in,O
100509,15,large,O
100509,15,infiltrative,O
100509,15,hypoattenuating,O
100509,15,right,O
100509,15,hilar/mediastinal,O
100509,15,mass,O
100509,15,.,O
100509,15,4,O
100509,15,.,O
100509,15,No,O
100509,15,evidence,O
100509,15,of,O
100509,15,metastases,O
100509,15,in,O
100509,15,the,O
100509,15,abdomen,O
100509,15,or,O
100509,15,pelvis,O
100509,15,.,O
100509,15,Slightly,O
100509,15,bulky,O
100509,15,left,O
100509,15,adrenal,O
100509,15,gland,O
100509,15,without,O
100509,15,discrete,O
100509,15,nodule,O
100509,15,or,O
100509,15,mass,O
100509,15,.,O
100509,15,5,O
100509,15,.,O
100509,15,Anasarca,O
100509,15,and,O
100509,15,small,O
100509,15,amount,O
100509,15,of,O
100509,15,peritoneal,O
100509,15,fluid,O
100509,15,collecting,O
100509,15,in,O
100509,15,the,O
100509,15,pelvis,O
100509,15,",",O
100509,15,likely,O
100509,15,related,O
100509,15,to,O
100509,15,edema,O
100509,15,.,O
100509,16,6,O
100509,16,.,O
100509,16,Interval,O
100509,16,tracheal,O
100509,16,stenting,O
100509,16,with,O
100509,16,improved,O
100509,16,caliber,O
100509,16,of,O
100509,16,airway,O
100509,16,.,O
100509,16,.,O
100509,16,[,O
100509,16,*,O
100509,16,*,O
100509,16,2172-8-27,O
100509,16,*,O
100509,16,*,O
100509,16,],O
100509,16,ECHO,O
100509,16,:,O
100509,16,Compared,O
100509,16,with,O
100509,16,the,O
100509,16,prior,O
100509,16,study,O
100509,16,(,O
100509,16,images,O
100509,16,reviewed,O
100509,16,),O
100509,16,of,O
100509,16,[,O
100509,16,*,O
100509,16,*,O
100509,16,2172-8-26,O
100509,16,*,O
100509,16,*,O
100509,16,],O
100509,16,",",O
100509,16,the,O
100509,16,size,O
100509,16,of,O
100509,16,the,O
100509,16,pericardial,O
100509,16,effusion,O
100509,16,is,O
100509,16,unchanged,O
100509,16,with,O
100509,16,no,O
100509,16,signs,O
100509,16,of,O
100509,16,tamponade,O
100509,16,.,O
100509,16,The,O
100509,16,left,O
100509,16,ventricle,O
100509,16,seems,O
100509,16,to,O
100509,16,be,O
100509,16,underfilled,O
100509,16,.,O
100509,16,.,O
100509,16,[,O
100509,16,*,O
100509,16,*,O
100509,16,8-28,O
100509,16,*,O
100509,16,*,O
100509,16,],O
100509,16,CT,O
100509,16,Head,O
100509,16,:,O
100509,16,1,O
100509,16,.,O
100509,16,Within,O
100509,16,limits,O
100509,16,of,O
100509,16,this,O
100509,16,modality,O
100509,16,",",O
100509,16,no,O
100509,16,evidence,O
100509,16,of,O
100509,16,enhancing,O
100509,16,mass,O
100509,16,or,O
100509,16,edema,O
100509,16,to,O
100509,16,suggest,O
100509,16,metastatic,O
100509,16,disease,O
100509,16,.,O
100509,17,2,O
100509,17,.,O
100509,17,Status,O
100509,17,post,O
100509,17,bilateral,O
100509,17,frontal,O
100509,17,craniotomy,O
100509,17,and,O
100509,17,probable,O
100509,17,aneurysm,O
100509,17,clipping,O
100509,17,with,O
100509,17,encephalomalacic,O
100509,17,changes,O
100509,17,in,O
100509,17,the,O
100509,17,right,O
100509,17,frontotemporal,O
100509,17,and,O
100509,17,left,O
100509,17,temporal,O
100509,17,lobes,O
100509,17,.,O
100509,17,No,O
100509,17,evidence,O
100509,17,of,O
100509,17,acute,O
100509,17,hemorrhage,O
100509,17,or,O
100509,17,infarct,O
100509,17,.,O
100509,17,3,O
100509,17,.,O
100509,17,Probable,O
100509,17,chronic,O
100509,17,bifrontal,O
100509,17,subdural,O
100509,17,hygromas,O
100509,17,with,O
100509,17,minimal,O
100509,17,mass,O
100509,17,effect,O
100509,17,on,O
100509,17,the,O
100509,17,subjacent,O
100509,17,frontal,O
100509,17,gyri,O
100509,17,;,O
100509,17,these,O
100509,17,may,O
100509,17,relate,O
100509,17,to,O
100509,17,the,O
100509,17,extensive,O
100509,17,remote,O
100509,17,surgery,O
100509,17,.,O
100509,17,[,O
100509,17,*,O
100509,17,*,O
100509,17,2172-9-2,O
100509,17,*,O
100509,17,*,O
100509,17,],O
100509,17,CT,O
100509,17,Head,O
100509,17,(,O
100509,17,performed,O
100509,17,due,O
100509,17,to,O
100509,17,worsened,O
100509,17,mental,O
100509,17,status,O
100509,17,),O
100509,17,:,O
100509,17,1,O
100509,17,.,O
100509,18,Unchanged,O
100509,18,examination,O
100509,18,from,O
100509,18,recent,O
100509,18,exam,O
100509,18,of,O
100509,18,[,O
100509,18,*,O
100509,18,*,O
100509,18,2172-8-28,O
100509,18,*,O
100509,18,*,O
100509,18,],O
100509,18,.,O
100509,18,2,O
100509,18,.,O
100509,18,Status,O
100509,18,post,O
100509,18,bilateral,O
100509,18,frontal,O
100509,18,craniotomies,O
100509,18,with,O
100509,18,aneurysm,O
100509,18,clipping,O
100509,18,and,O
100509,18,encephalomalcia,O
100509,18,",",O
100509,18,as,O
100509,18,described,O
100509,18,above,O
100509,18,.,O
100509,18,No,O
100509,18,evidence,O
100509,18,of,O
100509,18,acute,O
100509,18,hemorrhage,O
100509,18,or,O
100509,18,infarct,O
100509,18,.,O
100509,18,.,O
100509,18,[,O
100509,18,*,O
100509,18,*,O
100509,18,2172-9-3,O
100509,18,*,O
100509,18,*,O
100509,18,],O
100509,18,Renal,O
100509,18,US,O
100509,18,:,O
100509,18,1,O
100509,18,.,O
100509,18,Mildly,O
100509,18,echogenic,O
100509,18,kidneys,O
100509,18,consistent,O
100509,18,with,O
100509,18,medical,O
100509,18,renal,O
100509,18,disease,O
100509,18,.,O
100509,18,There,O
100509,18,is,O
100509,18,no,O
100509,18,evidence,O
100509,18,of,O
100509,18,hydronephrosis,O
100509,18,",",O
100509,18,stone,O
100509,18,",",O
100509,18,or,O
100509,18,mass,O
100509,18,.,O
100509,18,2,O
100509,18,.,O
100509,18,The,O
100509,18,left,O
100509,18,kidney,O
100509,18,remains,O
100509,18,atrophic,O
100509,18,and,O
100509,18,lobulated,O
100509,18,",",O
100509,18,similar,O
100509,18,to,O
100509,18,[,O
100509,18,*,O
100509,18,*,O
100509,18,2172-8-27,O
100509,18,*,O
100509,18,*,O
100509,18,],O
100509,18,.,O
100509,19,.,O
100509,19,[,O
100509,19,*,O
100509,19,*,O
100509,19,2172-9-4,O
100509,19,*,O
100509,19,*,O
100509,19,],O
100509,19,CT,O
100509,19,Chest,O
100509,19,w/o,O
100509,19,contrast,O
100509,19,(,O
100509,19,to,O
100509,19,evaluate,O
100509,19,tumor,O
100509,19,s/p,O
100509,19,XRT,O
100509,19,and,O
100509,19,chemo,O
100509,19,for,O
100509,19,future,O
100509,19,XRT,O
100509,19,sessions,O
100509,19,),O
100509,19,:,O
100509,19,1,O
100509,19,.,O
100509,19,Right,O
100509,19,anterior,O
100509,19,pneumothorax,O
100509,19,has,O
100509,19,resolved,O
100509,19,.,O
100509,19,2,O
100509,19,.,O
100509,19,Mixed,O
100509,19,response,O
100509,19,of,O
100509,19,the,O
100509,19,tumor,O
100509,19,to,O
100509,19,radiotherapy,O
100509,19,with,O
100509,19,a,O
100509,19,decrease,O
100509,19,of,O
100509,19,the,O
100509,19,central,O
100509,19,component,O
100509,19,of,O
100509,19,the,O
100509,19,tumor,O
100509,19,and,O
100509,19,a,O
100509,19,mixed,O
100509,19,response,O
100509,19,of,O
100509,19,the,O
100509,19,peripheral,O
100509,19,tumor,O
100509,19,components,O
100509,19,:,O
100509,19,3,O
100509,19,.,O
100509,19,The,O
100509,19,peripheral,O
100509,19,consolidations,O
100509,19,in,O
100509,19,the,O
100509,19,right,O
100509,19,upper,O
100509,19,lobe,O
100509,19,have,O
100509,19,overall,O
100509,19,decreased,O
100509,19,in,O
100509,19,size,O
100509,19,",",O
100509,19,however,O
100509,19,",",O
100509,19,a,O
100509,19,new,O
100509,19,cavitary,O
100509,19,lesion,O
100509,19,has,O
100509,19,formed,O
100509,19,measuring,O
100509,19,11,O
100509,19,x,O
100509,19,19,O
100509,19,mm,O
100509,19,.,O
100509,20,4,O
100509,20,.,O
100509,20,The,O
100509,20,peripheral,O
100509,20,consolidations,O
100509,20,in,O
100509,20,the,O
100509,20,right,O
100509,20,lower,O
100509,20,lobe,O
100509,20,and,O
100509,20,left,O
100509,20,lower,O
100509,20,lobe,O
100509,20,have,O
100509,20,increased,O
100509,20,in,O
100509,20,size,O
100509,20,",",O
100509,20,number,O
100509,20,and,O
100509,20,density,O
100509,20,and,O
100509,20,may,O
100509,20,be,O
100509,20,part,O
100509,20,of,O
100509,20,post-,O
100509,20,obstructive,O
100509,20,",",O
100509,20,post-radiotherapy,O
100509,20,",",O
100509,20,post-infectious,O
100509,20,",",O
100509,20,or,O
100509,20,acute,O
100509,20,inflammatory,O
100509,20,changes,O
100509,20,.,O
100509,20,5,O
100509,20,.,O
100509,20,Lymphangio-carcinomatosis,O
100509,20,in,O
100509,20,the,O
100509,20,right,O
100509,20,upper,O
100509,20,lobe,O
100509,20,.,O
100509,20,6,O
100509,20,.,O
100509,20,There,O
100509,20,is,O
100509,20,new,O
100509,20,small,O
100509,20,right,O
100509,20,pleural,O
100509,20,effusion,O
100509,20,and,O
100509,20,increased,O
100509,20,moderate,O
100509,20,left,O
100509,20,pleural,O
100509,20,effusion,O
100509,20,.,O
100509,20,7,O
100509,20,.,O
100509,20,Left,O
100509,20,adrenal,O
100509,20,gland,O
100509,20,mass,O
100509,20,is,O
100509,20,only,O
100509,20,partially,O
100509,20,visualized,O
100509,20,in,O
100509,20,this,O
100509,20,study,O
100509,20,.,O
100509,21,.,O
100509,21,[,O
100509,21,*,O
100509,21,*,O
100509,21,2172-9-3,O
100509,21,*,O
100509,21,*,O
100509,21,],O
100509,21,EEG,O
100509,21,:,O
100509,21,Markedly,O
100509,21,abnormal,O
100509,21,portable,O
100509,21,EEG,O
100509,21,due,O
100509,21,to,O
100509,21,the,O
100509,21,very,O
100509,21,disorganized,O
100509,21,and,O
100509,21,slow,O
100509,21,background,O
100509,21,rhythms,O
100509,21,.,O
100509,21,This,O
100509,21,suggests,O
100509,21,a,O
100509,21,widespread,O
100509,21,and,O
100509,21,moderately,O
100509,21,severe,O
100509,21,encephalopathy,O
100509,21,in,O
100509,21,both,O
100509,21,cortical,O
100509,21,and,O
100509,21,subcortical,O
100509,21,structures,O
100509,21,.,O
100509,21,Medications,O
100509,21,",",O
100509,21,metabolic,O
100509,21,disturbances,O
100509,21,",",O
100509,21,and,O
100509,21,infection,O
100509,21,are,O
100509,21,among,O
100509,21,the,O
100509,21,most,O
100509,21,common,O
100509,21,causes,O
100509,21,.,O
100509,21,Although,O
100509,21,there,O
100509,21,were,O
100509,21,fleeting,O
100509,21,asymmetries,O
100509,21,",",O
100509,21,there,O
100509,21,was,O
100509,21,no,O
100509,21,reliable,O
100509,21,area,O
100509,21,of,O
100509,21,focal,O
100509,21,slowing,O
100509,21,.,O
100509,21,Encephalopathies,O
100509,21,may,O
100509,21,obscure,O
100509,21,focal,O
100509,21,findings,O
100509,21,.,O
100509,21,There,O
100509,21,are,O
100509,21,some,O
100509,21,sharp,O
100509,21,features,O
100509,21,",",O
100509,21,but,O
100509,21,no,O
100509,21,clearly,O
100509,21,epileptiform,O
100509,21,abnormalities,O
100509,21,and,O
100509,21,no,O
100509,21,electrographic,O
100509,21,seizures,O
100509,21,.,O
100509,22,.,O
100509,22,[,O
100509,22,*,O
100509,22,*,O
100509,22,2172-9-5,O
100509,22,*,O
100509,22,*,O
100509,22,],O
100509,22,LENI,O
100509,22,:,O
100509,22,no,O
100509,22,DVT,O
100509,22,.,O
100509,22,[,O
100509,22,*,O
100509,22,*,O
100509,22,2172-9-5,O
100509,22,*,O
100509,22,*,O
100509,22,],O
100509,22,ECHO,O
100509,22,:,O
100509,22,final,O
100509,22,read,O
100509,22,pending,O
100509,22,.,O
100509,22,Micro,O
100509,22,:,O
100509,22,[,O
100509,22,*,O
100509,22,*,O
100509,22,2172-8-26,O
100509,22,*,O
100509,22,*,O
100509,22,],O
100509,22,Pleural,O
100509,22,fluid,O
100509,22,:,O
100509,22,GRAM,O
100509,22,STAIN,O
100509,22,(,O
100509,22,Final,O
100509,22,[,O
100509,22,*,O
100509,22,*,O
100509,22,2172-8-26,O
100509,22,*,O
100509,22,*,O
100509,22,],O
100509,22,),O
100509,22,:,O
100509,22,3+,O
100509,22,(,O
100509,22,5-10,O
100509,22,per,O
100509,22,1000X,O
100509,22,FIELD,O
100509,22,),O
100509,22,:,O
100509,22,POLYMORPHONUCLEAR,O
100509,22,LEUKOCYTES,O
100509,22,.,O
100509,22,NO,O
100509,22,MICROORGANISMS,O
100509,22,SEEN,O
100509,22,.,O
100509,22,FLUID,O
100509,22,CULTURE,O
100509,22,(,O
100509,22,Final,O
100509,22,[,O
100509,22,*,O
100509,22,*,O
100509,22,2172-8-29,O
100509,22,*,O
100509,22,*,O
100509,22,],O
100509,22,),O
100509,22,:,O
100509,22,NO,O
100509,22,GROWTH,O
100509,22,.,O
100509,23,ANAEROBIC,O
100509,23,CULTURE,O
100509,23,(,O
100509,23,Final,O
100509,23,[,O
100509,23,*,O
100509,23,*,O
100509,23,2172-9-1,O
100509,23,*,O
100509,23,*,O
100509,23,],O
100509,23,),O
100509,23,:,O
100509,23,NO,O
100509,23,GROWTH,O
100509,23,.,O
100509,23,ACID,O
100509,23,FAST,O
100509,23,SMEAR,O
100509,23,(,O
100509,23,Final,O
100509,23,[,O
100509,23,*,O
100509,23,*,O
100509,23,2172-8-27,O
100509,23,*,O
100509,23,*,O
100509,23,],O
100509,23,),O
100509,23,:,O
100509,23,no,O
100509,23,AFB,O
100509,23,seen,O
100509,23,on,O
100509,23,direct,O
100509,23,smear,O
100509,23,ACID,O
100509,23,FAST,O
100509,23,CULTURE,O
100509,23,(,O
100509,23,Preliminary,O
100509,23,),O
100509,23,:,O
100509,23,PENDING,O
100509,23,Cytology,O
100509,23,:,O
100509,23,Atypical,O
100509,23,cells,O
100509,23,",",O
100509,23,non-specific,O
100509,23,findings,O
100509,23,.,O
100509,23,[,O
100509,23,*,O
100509,23,*,O
100509,23,2172-9-4,O
100509,23,*,O
100509,23,*,O
100509,23,],O
100509,23,BAL,O
100509,23,:,O
100509,23,GRAM,O
100509,23,STAIN,O
100509,23,(,O
100509,23,Final,O
100509,23,[,O
100509,23,*,O
100509,23,*,O
100509,23,2172-9-4,O
100509,23,*,O
100509,23,*,O
100509,23,],O
100509,23,),O
100509,23,:,O
100509,23,1+,O
100509,23,(,O
100509,23,<,O
100509,23,1,O
100509,23,per,O
100509,23,1000X,O
100509,23,FIELD,O
100509,23,),O
100509,23,:,O
100509,23,POLYMORPHONUCLEAR,O
100509,23,LEUKOCYTES,O
100509,23,.,O
100509,24,1+,O
100509,24,(,O
100509,24,<,O
100509,24,1,O
100509,24,per,O
100509,24,1000X,O
100509,24,FIELD,O
100509,24,),O
100509,24,:,O
100509,24,GRAM,O
100509,24,NEGATIVE,O
100509,24,ROD,O
100509,24,(,O
100509,24,S,O
100509,24,),O
100509,24,.,O
100509,24,1+,O
100509,24,(,O
100509,24,<,O
100509,24,1,O
100509,24,per,O
100509,24,1000X,O
100509,24,FIELD,O
100509,24,),O
100509,24,:,O
100509,24,BUDDING,O
100509,24,YEAST,O
100509,24,WITH,O
100509,24,PSEUDOHYPHAE,O
100509,24,.,O
100509,24,RESPIRATORY,O
100509,24,CULTURE,O
100509,24,(,O
100509,24,Preliminary,O
100509,24,),O
100509,24,:,O
100509,24,FUNGAL,O
100509,24,CULTURE,O
100509,24,(,O
100509,24,Preliminary,O
100509,24,),O
100509,24,:,O
100509,24,.,O
100509,24,[,O
100509,24,*,O
100509,24,*,O
100509,24,2172-9-3,O
100509,24,*,O
100509,24,*,O
100509,24,],O
100509,24,CSF,O
100509,24,:,O
100509,24,GRAM,O
100509,24,STAIN,O
100509,24,(,O
100509,24,Final,O
100509,24,[,O
100509,24,*,O
100509,24,*,O
100509,24,2172-9-3,O
100509,24,*,O
100509,24,*,O
100509,24,],O
100509,24,),O
100509,24,:,O
100509,24,NO,O
100509,24,POLYMORPHONUCLEAR,O
100509,24,LEUKOCYTES,O
100509,24,SEEN,O
100509,24,.,O
100509,24,NO,O
100509,24,MICROORGANISMS,O
100509,24,SEEN,O
100509,24,.,O
100509,24,FLUID,O
100509,24,CULTURE,O
100509,24,(,O
100509,24,Preliminary,O
100509,24,),O
100509,24,:,O
100509,24,NO,O
100509,24,GROWTH,O
100509,24,.,O
100509,25,Cytology,O
100509,25,:,O
100509,25,no,O
100509,25,malignant,O
100509,25,cells,O
100509,25,.,O
100509,25,C.,O
100509,25,diff,O
100509,25,negative,O
100509,25,.,O
100509,25,[,O
100509,25,*,O
100509,25,*,O
100509,25,8-30,O
100509,25,*,O
100509,25,*,O
100509,25,],O
100509,25,Blood,O
100509,25,Cx,O
100509,25,?,O
100509,25,?,O
100509,25,?,O
100509,25,?,O
100509,25,?,O
100509,25,?,O
100509,25,NGTD,O
100509,25,[,O
100509,25,*,O
100509,25,*,O
100509,25,9-5,O
100509,25,*,O
100509,25,*,O
100509,25,],O
100509,25,Blooc,O
100509,25,cx,O
100509,25,-,O
100509,25,pending,O
100509,25,.,O
100509,25,Bronchoscopy,O
100509,25,[,O
100509,25,*,O
100509,25,*,O
100509,25,2172-9-4,O
100509,25,*,O
100509,25,*,O
100509,25,],O
100509,25,:,O
100509,25,lots,O
100509,25,of,O
100509,25,necrotic,O
100509,25,tissue,O
100509,25,noted,O
100509,25,",",O
100509,25,ETT,O
100509,25,tube,O
100509,25,dislodged,O
100509,25,between,O
100509,25,stent,O
100509,25,and,O
100509,25,tracheal,O
100509,25,wall,O
100509,25,",",O
100509,25,repositioned,O
100509,25,during,O
100509,25,bronch,O
100509,25,.,O
100509,25,Brief,O
100509,25,Hospital,O
100509,25,Course,O
100509,25,:,O
100509,25,[,O
100509,25,*,O
100509,25,*,O
100509,25,Hospital,O
100509,25,Unit,O
100509,25,Name,O
100509,25,153,O
100509,25,*,O
100509,25,*,O
100509,25,],O
100509,25,Course,O
100509,25,[,O
100509,25,*,O
100509,25,*,O
100509,25,Date,O
100509,25,range,O
100509,25,(,O
100509,25,3,O
100509,25,),O
100509,25,84902,O
100509,25,*,O
100509,25,*,O
100509,25,],O
100509,25,58F,O
100509,25,with,O
100509,25,likely,O
100509,25,small,O
100509,25,cell,O
100509,25,carcinoma,O
100509,25,complicated,O
100509,26,by,O
100509,26,SVC,O
100509,26,syndrome,O
100509,26,",",O
100509,26,airway,O
100509,26,compromise,O
100509,26,requiring,O
100509,26,Y-stent,O
100509,26,",",O
100509,26,pericardial,O
100509,26,effusion,O
100509,26,",",O
100509,26,resolved,O
100509,26,pleural,O
100509,26,effusion,O
100509,26,and,O
100509,26,pneumothorax,O
100509,26,",",O
100509,26,and,O
100509,26,electrolytes,O
100509,26,disturbances,O
100509,26,admitted,O
100509,26,to,O
100509,26,[,O
100509,26,*,O
100509,26,*,O
100509,26,Hospital,O
100509,26,Unit,O
100509,26,Name,O
100509,26,153,O
100509,26,*,O
100509,26,*,O
100509,26,],O
100509,26,for,O
100509,26,radiation,O
100509,26,decompression,O
100509,26,therapy,O
100509,26,and,O
100509,26,chemotherapy,B-Drug
100509,26,.,O
100509,26,Pt,O
100509,26,developed,O
100509,26,respiratory,O
100509,26,failure,O
100509,26,and,O
100509,26,renal,O
100509,26,failure,O
100509,26,.,O
100509,26,.,O
100509,26,#,O
100509,26,.,O
100509,26,Hypoxic,O
100509,26,respiratory,O
100509,26,failure,O
100509,26,:,O
100509,26,Pt,O
100509,26,was,O
100509,26,initially,O
100509,26,transferred,O
100509,26,from,O
100509,26,SICU,O
100509,26,to,O
100509,26,[,O
100509,26,*,O
100509,26,*,O
100509,26,Hospital,O
100509,26,Unit,O
100509,26,Name,O
100509,26,153,O
100509,26,*,O
100509,26,*,O
100509,26,],O
100509,26,on,O
100509,26,CPAP/PS,O
100509,26,.,O
100509,26,She,O
100509,26,developed,O
100509,26,increasing,O
100509,26,respiratory,O
100509,26,failure,O
100509,26,and,O
100509,26,was,O
100509,26,changed,O
100509,26,to,O
100509,26,AC,O
100509,26,mode,O
100509,26,.,O
100509,27,In,O
100509,27,the,O
100509,27,[,O
100509,27,*,O
100509,27,*,O
100509,27,Hospital,O
100509,27,Unit,O
100509,27,Name,O
100509,27,153,O
100509,27,*,O
100509,27,*,O
100509,27,],O
100509,27,",",O
100509,27,she,O
100509,27,underwent,O
100509,27,XRT,O
100509,27,x2,O
100509,27,and,O
100509,27,then,O
100509,27,chemotherapy,B-Drug
100509,27,for,O
100509,27,3,O
100509,27,days,O
100509,27,.,O
100509,27,Increased,O
100509,27,hypoxia,O
100509,27,may,O
100509,27,have,O
100509,27,been,O
100509,27,due,O
100509,27,to,O
100509,27,pneumothorax,O
100509,27,",",O
100509,27,which,O
100509,27,resolved,O
100509,27,",",O
100509,27,pleural,O
100509,27,effusions,O
100509,27,",",O
100509,27,atelectasis,O
100509,27,",",O
100509,27,possible,O
100509,27,VAP,O
100509,27,",",O
100509,27,tumor,O
100509,27,compression,O
100509,27,.,O
100509,27,During,O
100509,27,hypoxic,O
100509,27,episodes,O
100509,27,",",O
100509,27,pt,O
100509,27,underwent,O
100509,27,bronchoscopy,O
100509,27,twice,O
100509,27,",",O
100509,27,both,O
100509,27,times,O
100509,27,of,O
100509,27,which,O
100509,27,demonstrated,O
100509,27,the,O
100509,27,ETT,O
100509,27,lodged,O
100509,27,between,O
100509,27,tracheal,O
100509,27,wall,O
100509,27,and,O
100509,27,stent,O
100509,27,.,O
100509,27,Pt,O
100509,27,'s,O
100509,27,saturation,O
100509,27,improved,O
100509,27,with,O
100509,27,repositioning,O
100509,27,.,O
100509,28,Respiratory,O
100509,28,status,O
100509,28,also,O
100509,28,complicated,O
100509,28,by,O
100509,28,possible,O
100509,28,underlying,O
100509,28,COPD,O
100509,28,given,O
100509,28,smoking,O
100509,28,history,O
100509,28,with,O
100509,28,possible,O
100509,28,air,O
100509,28,stacking/trapping,O
100509,28,.,O
100509,28,Pt,O
100509,28,was,O
100509,28,started,O
100509,28,on,O
100509,28,vancomycin,B-Drug
100509,28,",",O
100509,28,cefepime,B-Drug
100509,28,and,O
100509,28,ciprofloxacin,B-Drug
100509,28,(,O
100509,28,started,O
100509,28,[,O
100509,28,*,O
100509,28,*,O
100509,28,2172-8-31,O
100509,28,*,O
100509,28,*,O
100509,28,],O
100509,28,for,O
100509,28,8,O
100509,28,day,O
100509,28,course,O
100509,28,),O
100509,28,for,O
100509,28,VAP,B-Reason
100509,28,.,O
100509,28,Vanco,B-Drug
100509,28,was,O
100509,28,later,O
100509,28,held,O
100509,28,as,O
100509,28,the,O
100509,28,level,O
100509,28,was,O
100509,28,elevated,O
100509,28,in,O
100509,28,the,O
100509,28,setting,O
100509,28,of,O
100509,28,renal,O
100509,28,failure,O
100509,28,.,O
100509,28,Patient's,O
100509,28,family,O
100509,28,decided,O
100509,28,to,O
100509,28,persue,O
100509,28,comfort,O
100509,28,only,O
100509,28,care,O
100509,28,on,O
100509,28,[,O
100509,28,*,O
100509,28,*,O
100509,28,2172-9-6,O
100509,28,*,O
100509,28,*,O
100509,28,],O
100509,28,",",O
100509,28,and,O
100509,28,she,O
100509,28,was,O
100509,28,terminally,O
100509,28,extubated,O
100509,28,.,O
100509,29,Patient,O
100509,29,expired,O
100509,29,15,O
100509,29,minutes,O
100509,29,later,O
100509,29,from,O
100509,29,respiratory,O
100509,29,failure,O
100509,29,and,O
100509,29,asystole,O
100509,29,secondary,O
100509,29,to,O
100509,29,lung,O
100509,29,cancer,O
100509,29,.,O
100509,29,.,O
100509,29,#,O
100509,29,Altered,O
100509,29,Mental,O
100509,29,Status,O
100509,29,:,O
100509,29,Pt,O
100509,29,had,O
100509,29,decline,O
100509,29,in,O
100509,29,mental,O
100509,29,status,O
100509,29,over,O
100509,29,time,O
100509,29,.,O
100509,29,She,O
100509,29,initially,O
100509,29,withdrew,O
100509,29,from,O
100509,29,noxious,O
100509,29,stimuli,O
100509,29,but,O
100509,29,later,O
100509,29,was,O
100509,29,less,O
100509,29,responsive,O
100509,29,.,O
100509,29,AMS,O
100509,29,continued,O
100509,29,despite,O
100509,29,sedation,O
100509,29,being,O
100509,29,off,O
100509,29,.,O
100509,29,AMS,O
100509,29,most,O
100509,29,likely,O
100509,29,due,O
100509,29,to,O
100509,29,toxic,O
100509,29,metabolic,O
100509,29,syndrome,O
100509,29,in,O
100509,29,setting,O
100509,29,of,O
100509,29,uremia,O
100509,29,and,O
100509,29,multi-system,O
100509,29,organ,O
100509,29,failure,O
100509,29,.,O
100509,29,Differential,O
100509,29,also,O
100509,29,included,O
100509,29,seizure,O
100509,29,(,O
100509,29,given,O
100509,29,hx,O
100509,29,of,O
100509,29,cerebral,O
100509,29,aneurysm,O
100509,29,repair,O
100509,29,",",O
100509,29,on,O
100509,29,anti-epileptics,O
100509,29,presumably,O
100509,29,prophylactically,O
100509,29,),O
100509,29,although,O
100509,29,EEG,O
100509,29,did,O
100509,29,not,O
100509,29,demonstrate,O
100509,29,focal,O
100509,29,abnormalities,O
100509,29,.,O
100509,30,LP,O
100509,30,did,O
100509,30,not,O
100509,30,demonstrate,O
100509,30,infection,O
100509,30,or,O
100509,30,spread,O
100509,30,of,O
100509,30,malignancy,O
100509,30,.,O
100509,30,CT,O
100509,30,head,O
100509,30,[,O
100509,30,*,O
100509,30,*,O
100509,30,2172-9-2,O
100509,30,*,O
100509,30,*,O
100509,30,],O
100509,30,negative,O
100509,30,for,O
100509,30,acute,O
100509,30,process,O
100509,30,.,O
100509,30,.,O
100509,30,#,O
100509,30,.,O
100509,30,Small,O
100509,30,cell,O
100509,30,lung,O
100509,30,carcinoma,O
100509,30,:,O
100509,30,per,O
100509,30,pathology,O
100509,30,",",O
100509,30,the,O
100509,30,tumor,O
100509,30,probably,O
100509,30,fits,O
100509,30,into,O
100509,30,the,O
100509,30,spectrum,O
100509,30,of,O
100509,30,a,O
100509,30,small,O
100509,30,cell,O
100509,30,carcinoma,O
100509,30,of,O
100509,30,lung,O
100509,30,.,O
100509,30,Given,O
100509,30,associated,O
100509,30,SVC,O
100509,30,syndrome,O
100509,30,",",O
100509,30,prognosis,O
100509,30,poor,O
100509,30,.,O
100509,30,CT,O
100509,30,head/,O
100509,30,[,O
100509,30,*,O
100509,30,*,O
100509,30,Last,O
100509,30,Name,O
100509,30,(,O
100509,30,un,O
100509,30,),O
100509,30,103,O
100509,30,*,O
100509,30,*,O
100509,30,],O
100509,30,/pelvis,O
100509,30,negative,O
100509,30,for,O
100509,30,metastases,O
100509,30,.,O
100509,31,Pt,O
100509,31,underwent,O
100509,31,3,O
100509,31,days,O
100509,31,of,O
100509,31,chemotherapy,B-Drug
100509,31,and,O
100509,31,2,O
100509,31,sessions,O
100509,31,of,O
100509,31,XRT,O
100509,31,.,O
100509,31,Initially,O
100509,31,",",O
100509,31,XRT,O
100509,31,was,O
100509,31,clinical,O
100509,31,emergency,O
100509,31,-,O
100509,31,normal,O
100509,31,and,O
100509,31,pathologic,O
100509,31,tissue,O
100509,31,was,O
100509,31,likely,O
100509,31,treated,O
100509,31,;,O
100509,31,necrotic,O
100509,31,tissue,O
100509,31,noted,O
100509,31,on,O
100509,31,bronchoscopy,O
100509,31,[,O
100509,31,*,O
100509,31,*,O
100509,31,2172-9-4,O
100509,31,*,O
100509,31,*,O
100509,31,],O
100509,31,.,O
100509,31,Pt,O
100509,31,was,O
100509,31,to,O
100509,31,undergo,O
100509,31,formal,O
100509,31,tissue,O
100509,31,planning,O
100509,31,session,O
100509,31,on,O
100509,31,[,O
100509,31,*,O
100509,31,*,O
100509,31,2172-9-8,O
100509,31,*,O
100509,31,*,O
100509,31,],O
100509,31,to,O
100509,31,better,O
100509,31,delineate,O
100509,31,area,O
100509,31,of,O
100509,31,radiation,O
100509,31,however,O
100509,31,family,O
100509,31,decided,O
100509,31,to,O
100509,31,persue,O
100509,31,comfort,O
100509,31,only,O
100509,31,care,O
100509,31,on,O
100509,31,[,O
100509,31,*,O
100509,31,*,O
100509,31,2172-9-6,O
100509,31,*,O
100509,31,*,O
100509,31,],O
100509,31,.,O
100509,32,.,O
100509,32,#,O
100509,32,Acute,B-ADE
100509,32,Renal,I-ADE
100509,32,failure,I-ADE
100509,32,:,O
100509,32,In,O
100509,32,setting,O
100509,32,of,O
100509,32,chemo,B-Drug
100509,32,with,O
100509,32,carboplatin,B-Drug
100509,32,.,O
100509,32,Urine,O
100509,32,casts,O
100509,32,consistent,O
100509,32,with,O
100509,32,ATN,O
100509,32,.,O
100509,32,Uric,O
100509,32,acid,O
100509,32,and,O
100509,32,electrolytes,O
100509,32,elevated,O
100509,32,4-5d,O
100509,32,post,O
100509,32,chemotherapy,B-Drug
100509,32,concerning,O
100509,32,for,O
100509,32,tumor,B-ADE
100509,32,lysis,I-ADE
100509,32,syndrome,I-ADE
100509,32,.,O
100509,32,The,O
100509,32,next,O
100509,32,therapeutic,O
100509,32,step,O
100509,32,was,O
100509,32,dialysis,O
100509,32,as,O
100509,32,patient,O
100509,32,became,O
100509,32,oliguric,O
100509,32,despite,O
100509,32,volume,O
100509,32,overload,O
100509,32,but,O
100509,32,the,O
100509,32,family,O
100509,32,wished,O
100509,32,for,O
100509,32,comfort,O
100509,32,only,O
100509,32,care,O
100509,32,given,O
100509,32,dismal,O
100509,32,prognosis,O
100509,32,of,O
100509,32,her,O
100509,32,lung,O
100509,32,cancer,O
100509,32,.,O
100509,32,.,O
100509,32,#,O
100509,32,.,O
100509,32,Metabolic,O
100509,32,acidosis,O
100509,32,:,O
100509,32,Originally,O
100509,32,thought,O
100509,32,to,O
100509,32,be,O
100509,32,non-gap,O
100509,32,metabolic,O
100509,32,acidosis,O
100509,32,due,O
100509,32,to,O
100509,32,hypoaldosteronism,O
100509,32,and,O
100509,32,type,O
100509,32,IV,O
100509,32,RTA,O
100509,32,.,O
100509,33,With,O
100509,33,low,O
100509,33,albumin,O
100509,33,",",O
100509,33,however,O
100509,33,",",O
100509,33,this,O
100509,33,is,O
100509,33,a,O
100509,33,gap,O
100509,33,metabolic,O
100509,33,acidosis,O
100509,33,",",O
100509,33,most,O
100509,33,likely,O
100509,33,due,O
100509,33,to,O
100509,33,uremia,O
100509,33,.,O
100509,33,Unable,O
100509,33,to,O
100509,33,increase,O
100509,33,RR,O
100509,33,to,O
100509,33,compensate,O
100509,33,due,O
100509,33,to,O
100509,33,concern,O
100509,33,for,O
100509,33,auto-peeping,O
100509,33,in,O
100509,33,setting,O
100509,33,of,O
100509,33,possible,O
100509,33,COPD,O
100509,33,.,O
100509,33,Goal,O
100509,33,pH,O
100509,33,is,O
100509,33,7.3-7.35,O
100509,33,.,O
100509,33,On,O
100509,33,[,O
100509,33,*,O
100509,33,*,O
100509,33,2172-9-5,O
100509,33,*,O
100509,33,*,O
100509,33,],O
100509,33,",",O
100509,33,pt,O
100509,33,'s,O
100509,33,acidosis,O
100509,33,worsened,O
100509,33,with,O
100509,33,pH,O
100509,33,7.16-7.18,O
100509,33,.,O
100509,33,Despite,O
100509,33,adjusting,O
100509,33,ETT,O
100509,33,placement,O
100509,33,and,O
100509,33,decreasing,O
100509,33,RR,O
100509,33,to,O
100509,33,reduce,O
100509,33,auto-peep,O
100509,33,",",O
100509,33,pt,O
100509,33,'s,O
100509,33,acidosis,O
100509,33,worsened,O
100509,33,.,O
100509,33,Bicarbonate,O
100509,33,was,O
100509,33,given,O
100509,33,.,O
100509,34,.,O
100509,34,#,O
100509,34,Tachycardia/Hypotension,O
100509,34,?,O
100509,34,?,O
100509,34,?,O
100509,34,?,O
100509,34,?,O
100509,34,?,O
100509,34,Pt,O
100509,34,with,O
100509,34,tachycardia,O
100509,34,to,O
100509,34,140s,O
100509,34,and,O
100509,34,episodes,O
100509,34,of,O
100509,34,hypotension,O
100509,34,to,O
100509,34,SBP,O
100509,34,low,O
100509,34,80s,O
100509,34,.,O
100509,34,Pt,O
100509,34,with,O
100509,34,new,O
100509,34,A-fib,O
100509,34,on,O
100509,34,telemetry,O
100509,34,and,O
100509,34,EKG,O
100509,34,.,O
100509,34,DDx,O
100509,34,includes,O
100509,34,possible,O
100509,34,enlarging,O
100509,34,pericardial,O
100509,34,effusion/tamponade,O
100509,34,but,O
100509,34,pulsus,O
100509,34,paradoxus,O
100509,34,was,O
100509,34,normal,O
100509,34,and,O
100509,34,ECHO,O
100509,34,[,O
100509,34,*,O
100509,34,*,O
100509,34,2172-9-5,O
100509,34,*,O
100509,34,*,O
100509,34,],O
100509,34,was,O
100509,34,unchanged,O
100509,34,from,O
100509,34,prior,O
100509,34,.,O
100509,34,No,O
100509,34,pneumothorax,O
100509,34,seen,O
100509,34,on,O
100509,34,CXR,O
100509,34,.,O
100509,34,Unable,O
100509,34,to,O
100509,34,assess,O
100509,34,for,O
100509,34,PE,O
100509,34,by,O
100509,34,CTA,O
100509,34,as,O
100509,34,pt,O
100509,34,in,O
100509,34,renal,O
100509,34,failure,O
100509,34,and,O
100509,34,VQ,O
100509,34,would,O
100509,34,not,O
100509,34,be,O
100509,34,helpful,O
100509,34,in,O
100509,34,setting,O
100509,34,of,O
100509,34,other,O
100509,34,lung,O
100509,34,pathology,O
100509,34,.,O
100509,35,LENI's,O
100509,35,negative,O
100509,35,for,O
100509,35,DVT,O
100509,35,.,O
100509,35,PE,O
100509,35,likely,O
100509,35,given,O
100509,35,malignancy,O
100509,35,and,O
100509,35,prolonged,O
100509,35,bed,O
100509,35,rest,O
100509,35,but,O
100509,35,unable,O
100509,35,to,O
100509,35,do,O
100509,35,CTA,O
100509,35,given,O
100509,35,renal,O
100509,35,failure,O
100509,35,and,O
100509,35,VQ,O
100509,35,scan,O
100509,35,not,O
100509,35,helpful,O
100509,35,in,O
100509,35,setting,O
100509,35,of,O
100509,35,lung,O
100509,35,changes,O
100509,35,.,O
100509,35,Even,O
100509,35,if,O
100509,35,it,O
100509,35,had,O
100509,35,been,O
100509,35,positive,O
100509,35,",",O
100509,35,heme/onc,O
100509,35,recommended,O
100509,35,against,O
100509,35,anti-coagulation,B-Drug
100509,35,in,O
100509,35,setting,O
100509,35,of,O
100509,35,possible,O
100509,35,tumor,O
100509,35,necrosis/hemorrhage,O
100509,35,.,O
100509,35,Pt,O
100509,35,remained,O
100509,35,tachycardic,O
100509,35,to,O
100509,35,130s,O
100509,35,despite,O
100509,35,numerous,O
100509,35,fluid,B-Drug
100509,35,boluses,O
100509,35,.,O
100509,35,.,O
100509,35,#,O
100509,35,.,O
100509,35,Electrolyte,O
100509,35,disturbances,O
100509,35,:,O
100509,35,Pt,O
100509,35,developed,O
100509,35,hypernatremia,O
100509,35,on,O
100509,35,[,O
100509,35,*,O
100509,35,*,O
100509,35,2172-9-4,O
100509,35,*,O
100509,35,*,O
100509,35,],O
100509,35,most,O
100509,35,likley,O
100509,35,due,O
100509,35,to,O
100509,35,dehydration,B-Reason
100509,35,with,I-Reason
100509,35,free,I-Reason
100509,35,water,I-Reason
100509,35,deficit,I-Reason
100509,35,of,O
100509,35,1.4L,O
100509,35,",",O
100509,35,started,O
100509,35,on,O
100509,35,D5W,B-Drug
100509,35,.,O
100509,36,Pt,O
100509,36,had,O
100509,36,hyponatremia,O
100509,36,and,O
100509,36,hyperkalemia,O
100509,36,on,O
100509,36,admission,O
100509,36,",",O
100509,36,both,O
100509,36,resolved,O
100509,36,.,O
100509,36,Unclear,O
100509,36,etiology,O
100509,36,of,O
100509,36,electrolyte,O
100509,36,disturbances,O
100509,36,on,O
100509,36,admission-,O
100509,36,hyponatremia,O
100509,36,thought,O
100509,36,to,O
100509,36,be,O
100509,36,secondary,O
100509,36,to,O
100509,36,possible,O
100509,36,adrenal,O
100509,36,insufficency,O
100509,36,(,O
100509,36,now,O
100509,36,discarded,O
100509,36,),O
100509,36,or,O
100509,36,possibly,O
100509,36,SIADH,O
100509,36,.,O
100509,36,Low,O
100509,36,UNa,O
100509,36,does,O
100509,36,not,O
100509,36,exclude,O
100509,36,SIADH,O
100509,36,;,O
100509,36,renal,O
100509,36,recommended,O
100509,36,rechecking,O
100509,36,urine,O
100509,36,lytes,O
100509,36,with,O
100509,36,saline,O
100509,36,load,O
100509,36,",",O
100509,36,whcih,O
100509,36,was,O
100509,36,not,O
100509,36,done,O
100509,36,in,O
100509,36,setting,O
100509,36,of,O
100509,36,pt,O
100509,36,?,O
100509,36,?,O
100509,36,?,O
100509,36,?,O
100509,36,?,O
100509,36,?,O
100509,36,s,O
100509,36,other,O
100509,36,medical,O
100509,36,issues,O
100509,36,.,O
100509,36,Hyperkalemia,O
100509,36,originally,O
100509,36,attributed,O
100509,36,to,O
100509,36,hypoaldosteronism,O
100509,36,and,O
100509,36,Type,O
100509,36,IV,O
100509,36,RTA,O
100509,36,",",O
100509,36,but,O
100509,36,unlikely,O
100509,36,per,O
100509,36,endocrine,O
100509,36,because,O
100509,36,of,O
100509,36,low,O
100509,36,urine,O
100509,36,sodium,O
100509,36,.,O
100509,37,.,O
100509,37,#,O
100509,37,.,O
100509,37,SVC,O
100509,37,syndrome,O
100509,37,:,O
100509,37,Incomplete,O
100509,37,occlusion,O
100509,37,of,O
100509,37,SVC,O
100509,37,;,O
100509,37,near,O
100509,37,complete,O
100509,37,occlusion,O
100509,37,of,O
100509,37,brachiocephalic,O
100509,37,veins,O
100509,37,.,O
100509,37,Clinically,O
100509,37,identified,O
100509,37,by,O
100509,37,upper,O
100509,37,extremity,O
100509,37,and,O
100509,37,facial,O
100509,37,swelling/plethora,O
100509,37,and,O
100509,37,mottled,O
100509,37,skin,O
100509,37,.,O
100509,37,Also,O
100509,37,with,O
100509,37,scleral,O
100509,37,edema,O
100509,37,.,O
100509,37,Unable,O
100509,37,to,O
100509,37,assess,O
100509,37,jugular,O
100509,37,venous,O
100509,37,distension,O
100509,37,given,O
100509,37,considerable,O
100509,37,swelling,O
100509,37,.,O
100509,37,Seen,O
100509,37,in,O
100509,37,appoximately,O
100509,37,10,O
100509,37,%,O
100509,37,cases,O
100509,37,of,O
100509,37,SSLC,O
100509,37,.,O
100509,37,Improved,O
100509,37,edema,O
100509,37,on,O
100509,37,exam,O
100509,37,compared,O
100509,37,to,O
100509,37,admission,O
100509,37,.,O
100509,37,SVC,O
100509,37,syndrome,O
100509,37,occurred,O
100509,37,after,O
100509,37,Y-stent,O
100509,37,placed,O
100509,37,.,O
100509,37,Possible,O
100509,37,that,O
100509,37,tumor,O
100509,37,pushing,O
100509,37,into,O
100509,37,trachea,O
100509,37,shifted,O
100509,37,to,O
100509,37,compress,O
100509,37,SVC,O
100509,37,after,O
100509,37,stent,O
100509,37,placement,O
100509,37,.,O
100509,38,She,O
100509,38,underwent,O
100509,38,radiation,O
100509,38,therapy,O
100509,38,and,O
100509,38,chemotherapy,B-Drug
100509,38,for,O
100509,38,decompression,B-Reason
100509,38,.,O
100509,38,.,O
100509,38,#,O
100509,38,.,O
100509,38,Pleural,O
100509,38,effusion,O
100509,38,:,O
100509,38,s/p,O
100509,38,right,O
100509,38,pigtail,O
100509,38,catheter,O
100509,38,placement,O
100509,38,[,O
100509,38,*,O
100509,38,*,O
100509,38,2172-8-25,O
100509,38,*,O
100509,38,*,O
100509,38,],O
100509,38,",",O
100509,38,removed,O
100509,38,[,O
100509,38,*,O
100509,38,*,O
100509,38,2172-8-31,O
100509,38,*,O
100509,38,*,O
100509,38,],O
100509,38,.,O
100509,38,LDH,O
100509,38,effusion/serum,O
100509,38,0.68,O
100509,38,(,O
100509,38,exudate,O
100509,38,by,O
100509,38,Light,O
100509,38,?,O
100509,38,?,O
100509,38,?,O
100509,38,?,O
100509,38,?,O
100509,38,?,O
100509,38,s,O
100509,38,criteria,O
100509,38,),O
100509,38,.,O
100509,38,Greatest,O
100509,38,concern,O
100509,38,for,O
100509,38,malignant,O
100509,38,effusion,O
100509,38,however,O
100509,38,cytology,O
100509,38,was,O
100509,38,nonspecific,O
100509,38,.,O
100509,38,Cultures,O
100509,38,of,O
100509,38,fluid,O
100509,38,all,O
100509,38,preliminary,O
100509,38,negative,O
100509,38,.,O
100509,38,.,O
100509,38,#,O
100509,38,.,O
100509,38,Pneumothorax,O
100509,38,:,O
100509,38,Developed,O
100509,38,pneumothorax,O
100509,38,in,O
100509,38,setting,O
100509,38,of,O
100509,38,re-intubation,O
100509,38,that,O
100509,38,resolved,O
100509,38,after,O
100509,38,chest,O
100509,38,tube,O
100509,38,placement,O
100509,38,.,O
100509,39,.,O
100509,39,#,O
100509,39,.,O
100509,39,Pericardial,O
100509,39,effusion,O
100509,39,:,O
100509,39,Suspected,O
100509,39,by,O
100509,39,cardiology,O
100509,39,to,O
100509,39,be,O
100509,39,malignant,O
100509,39,effusion,O
100509,39,.,O
100509,39,Felt,O
100509,39,not,O
100509,39,to,O
100509,39,be,O
100509,39,large,O
100509,39,enough,O
100509,39,for,O
100509,39,percutaneous,O
100509,39,drainage,O
100509,39,.,O
100509,39,EKG,O
100509,39,without,O
100509,39,signs,O
100509,39,of,O
100509,39,electrical,O
100509,39,alternans,O
100509,39,but,O
100509,39,does,O
100509,39,have,O
100509,39,low,O
100509,39,voltages,O
100509,39,.,O
100509,39,Repeat,O
100509,39,ECHO,O
100509,39,done,O
100509,39,[,O
100509,39,*,O
100509,39,*,O
100509,39,2172-9-5,O
100509,39,*,O
100509,39,*,O
100509,39,],O
100509,39,in,O
100509,39,setting,O
100509,39,of,O
100509,39,hypotension,O
100509,39,demonstrated,O
100509,39,no,O
100509,39,change,O
100509,39,in,O
100509,39,pericardial,O
100509,39,effusion,O
100509,39,.,O
100509,39,.,O
100509,39,#,O
100509,39,Sinus,O
100509,39,Pause,O
100509,39,on,O
100509,39,telemetry,O
100509,39,:,O
100509,39,Pt,O
100509,39,had,O
100509,39,episodes,O
100509,39,of,O
100509,39,sinus,O
100509,39,pauses,O
100509,39,on,O
100509,39,tele,O
100509,39,night,O
100509,39,of,O
100509,39,[,O
100509,39,*,O
100509,39,*,O
100509,39,8-30,O
100509,39,*,O
100509,39,*,O
100509,39,],O
100509,39,with,O
100509,39,turning,O
100509,39,to,O
100509,39,right,O
100509,39,side,O
100509,39,.,O
100509,40,Occurred,O
100509,40,again,O
100509,40,[,O
100509,40,*,O
100509,40,*,O
100509,40,2172-9-4,O
100509,40,*,O
100509,40,*,O
100509,40,],O
100509,40,again,O
100509,40,with,O
100509,40,re-positioning,O
100509,40,.,O
100509,40,Metoprolol,B-Drug
100509,40,was,O
100509,40,held,O
100509,40,and,O
100509,40,glucagon,B-Drug
100509,40,given,O
100509,40,in,O
100509,40,case,O
100509,40,this,O
100509,40,was,O
100509,40,due,O
100509,40,to,O
100509,40,beta,B-ADE
100509,40,blocker,I-ADE
100509,40,toxicity,I-ADE
100509,40,",",O
100509,40,but,O
100509,40,pauses,O
100509,40,decreased,O
100509,40,in,O
100509,40,frequency,O
100509,40,and,O
100509,40,duration,O
100509,40,on,O
100509,40,their,O
100509,40,own,O
100509,40,without,O
100509,40,intervention,O
100509,40,.,O
100509,40,Cardiology,O
100509,40,consulted,O
100509,40,who,O
100509,40,felt,O
100509,40,it,O
100509,40,was,O
100509,40,vagally,O
100509,40,mediated,O
100509,40,.,O
100509,40,[,O
100509,40,*,O
100509,40,*,O
100509,40,Month,O
100509,40,(,O
100509,40,only,O
100509,40,),O
100509,40,116,O
100509,40,*,O
100509,40,*,O
100509,40,],O
100509,40,have,O
100509,40,been,O
100509,40,due,O
100509,40,to,O
100509,40,ETT,O
100509,40,tube,O
100509,40,displacement,O
100509,40,pressing,O
100509,40,on,O
100509,40,carotid,O
100509,40,when,O
100509,40,pt,O
100509,40,was,O
100509,40,turned,O
100509,40,.,O
100509,41,.,O
100509,41,#,O
100509,41,Leukopenia,B-ADE
100509,41,/,O
100509,41,thrombocytopenia,B-ADE
100509,41,?,O
100509,41,?,O
100509,41,?,O
100509,41,?,O
100509,41,?,O
100509,41,?,O
100509,41,Most,O
100509,41,likely,O
100509,41,due,O
100509,41,to,O
100509,41,chemotherapy,B-Drug
100509,41,and,O
100509,41,no,O
100509,41,improvement,O
100509,41,in,O
100509,41,counts,O
100509,41,on,O
100509,41,neupogen,B-Drug
100509,41,.,O
100509,41,She,O
100509,41,was,O
100509,41,repeatedly,O
100509,41,pan-cultured,O
100509,41,with,O
100509,41,negative,O
100509,41,results,O
100509,41,.,O
100509,41,.,O
100509,41,#,O
100509,41,.,O
100509,41,Anemia,O
100509,41,:,O
100509,41,Normocytic,O
100509,41,and,O
100509,41,likely,O
100509,41,due,O
100509,41,to,O
100509,41,anemia,O
100509,41,of,O
100509,41,chronic,O
100509,41,disease,O
100509,41,given,O
100509,41,malignancy,O
100509,41,.,O
100509,41,Hemolysis,O
100509,41,labs,O
100509,41,were,O
100509,41,negative,O
100509,41,.,O
100509,41,.,O
100509,41,#,O
100509,41,s/p,O
100509,41,cerebral,O
100509,41,aneurysm,O
100509,41,repair,O
100509,41,:,O
100509,41,History,O
100509,41,of,O
100509,41,cerebral,O
100509,41,aneurysm,O
100509,41,repair,O
100509,41,with,O
100509,41,a,O
100509,41,number,O
100509,41,of,O
100509,41,chronic,O
100509,41,changes,O
100509,41,on,O
100509,41,head,O
100509,41,CT,O
100509,41,.,O
100509,42,Her,O
100509,42,antiepileptic,B-Drug
100509,42,medications,I-Drug
100509,42,were,O
100509,42,continued,O
100509,42,.,O
100509,42,Medications,O
100509,42,on,O
100509,42,Admission,O
100509,42,:,O
100509,42,Home,O
100509,42,medications,O
100509,42,:,O
100509,42,Metoprolol,B-Drug
100509,42,Omeprazole,B-Drug
100509,42,Levetiracetam,B-Drug
100509,42,Carbatrol,B-Drug
100509,42,Medications,O
100509,42,on,O
100509,42,transfer,O
100509,42,to,O
100509,42,[,O
100509,42,*,O
100509,42,*,O
100509,42,Hospital,O
100509,42,Unit,O
100509,42,Name,O
100509,42,153,O
100509,42,*,O
100509,42,*,O
100509,42,],O
100509,42,[,O
100509,42,*,O
100509,42,*,O
100509,42,2172-8-27,O
100509,42,*,O
100509,42,*,O
100509,42,],O
100509,42,:,O
100509,42,Furosemide,B-Drug
100509,42,10,O
100509,42,mg,O
100509,42,IV,O
100509,42,ONCE,O
100509,42,Duration,O
100509,42,:,O
100509,42,1,O
100509,42,Doses,O
100509,42,Carbamazepine,B-Drug
100509,42,900,O
100509,42,mg,O
100509,42,PO,O
100509,42,QPM,O
100509,42,Carbamazepine,B-Drug
100509,42,400,O
100509,42,mg,O
100509,42,PO,O
100509,42,QAM,O
100509,42,Artificial,B-Drug
100509,42,Tears,I-Drug
100509,42,Preserv,I-Drug
100509,42,.,I-Drug
100509,42,Free,I-Drug
100509,42,1-2,O
100509,42,DROP,O
100509,42,BOTH,O
100509,42,EYES,O
100509,42,PRN,O
100509,42,dry,B-Reason
100509,42,eyes,I-Reason
100509,42,Potassium,B-Drug
100509,42,Phosphate,I-Drug
100509,42,IV,O
100509,42,Sliding,O
100509,42,Scale,O
100509,42,Insulin,B-Drug
100509,42,SC,O
100509,42,Sliding,O
100509,42,Scale,O
100509,42,Insulin,B-Drug
100509,42,Regular,I-Drug
100509,42,10,O
100509,42,UNIT,O
100509,42,IV,O
100509,42,ONCE,O
100509,42,",",O
100509,42,Dextrose,B-Drug
100509,42,50,O
100509,42,%,O
100509,42,25,O
100509,42,gm,O
100509,42,IV,O
100509,42,ONCE,O
100509,42,Duration,O
100509,42,:,O
100509,42,1,O
100509,42,Doses,O
100509,42,08/20,O
100509,42,@,O
100509,42,0608,O
100509,43,Propofol,B-Drug
100509,43,20-50,O
100509,43,mcg/kg/min,O
100509,43,IV,O
100509,43,DRIP,O
100509,43,TITRATE,O
100509,43,TO,O
100509,43,moderate/heavy,B-Reason
100509,43,sedation,I-Reason
100509,43,Chlorhexidine,B-Drug
100509,43,Gluconate,I-Drug
100509,43,0.12,O
100509,43,%,O
100509,43,Oral,O
100509,43,Rinse,O
100509,43,15,O
100509,43,mL,O
100509,43,ORAL,O
100509,43,[,O
100509,43,*,O
100509,43,*,O
100509,43,Hospital1,O
100509,43,*,O
100509,43,*,O
100509,43,],O
100509,43,Hydrocortisone,B-Drug
100509,43,Na,O
100509,43,Succ,O
100509,43,.,O
100509,43,100,O
100509,43,mg,O
100509,43,IV,O
100509,43,Q8H,O
100509,43,Nicotine,B-Drug
100509,43,Patch,O
100509,43,14,O
100509,43,mg,O
100509,43,TD,O
100509,43,DAILY,O
100509,43,LeVETiracetam,B-Drug
100509,43,500,O
100509,43,mg,O
100509,43,IV,O
100509,43,BID,O
100509,43,Magnesium,B-Drug
100509,43,Sulfate,I-Drug
100509,43,IV,O
100509,43,Sliding,O
100509,43,Scale,O
100509,43,Calcium,B-Drug
100509,43,Gluconate,I-Drug
100509,43,IV,O
100509,43,Sliding,O
100509,43,Scale,O
100509,43,Potassium,B-Drug
100509,43,Chloride,I-Drug
100509,43,IV,O
100509,43,Sliding,O
100509,43,Scale,O
100509,43,Albuterol-Ipratropium,B-Drug
100509,43,[,O
100509,43,*,O
100509,43,*,O
100509,43,1-10,O
100509,43,*,O
100509,43,*,O
100509,43,],O
100509,43,PUFF,O
100509,43,IH,O
100509,43,Q6H,O
100509,43,Pantoprazole,B-Drug
100509,43,40,O
100509,43,mg,O
100509,43,IV,O
100509,43,Q24H,O
100509,43,Heparin,B-Drug
100509,43,5000,O
100509,43,UNIT,O
100509,43,SC,O
100509,43,TID,O
100509,43,Fentanyl,B-Drug
100509,43,Citrate,I-Drug
100509,43,25-100,O
100509,43,mcg,O
100509,43,IV,O
100509,43,Q6H,O
100509,43,:,O
100509,43,PRN,O
100509,43,Sedation,B-Reason
100509,43,Discharge,O
100509,43,Medications,O
100509,43,:,O
100509,43,Expired,O
100509,43,Discharge,O
100509,43,Disposition,O
100509,43,:,O
100509,43,Expired,O
100509,43,Discharge,O
100509,43,Diagnosis,O
100509,43,:,O
100509,44,Expired,O
100509,44,Discharge,O
100509,44,Condition,O
100509,44,:,O
100509,44,Expired,O
100509,44,Discharge,O
100509,44,Instructions,O
100509,44,:,O
100509,44,Expired,O
100509,44,Followup,O
100509,44,Instructions,O
100509,44,:,O
100509,44,Expired,O
100509,44,[,O
100509,44,*,O
100509,44,*,O
100509,44,First,O
100509,44,Name8,O
100509,44,(,O
100509,44,NamePattern2,O
100509,44,),O
100509,44,*,O
100509,44,*,O
100509,44,],O
100509,44,[,O
100509,44,*,O
100509,44,*,O
100509,44,Last,O
100509,44,Name,O
100509,44,(,O
100509,44,NamePattern1,O
100509,44,),O
100509,44,2437,O
100509,44,*,O
100509,44,*,O
100509,44,],O
100509,44,MD,O
100509,44,[,O
100509,44,*,O
100509,44,*,O
100509,44,MD,O
100509,44,Number,O
100509,44,(,O
100509,44,1,O
100509,44,),O
100509,44,2438,O
100509,44,*,O
100509,44,*,O
100509,44,],O
